Effect of Pravastatin on malondialdehyde-modified low-density lipoprotein levels and coronary plaque regression as determined by three-dimensional intravascular ultrasoundTANI, Shigemasa; WATANABE, Ikuyoshi; ANAZAWA, Takeo et al.The American journal of cardiology. 2005, Vol 96, Num 8, pp 1089-1094, issn 0002-9149, 6 p.Article

Association of plasma level of malondialdehyde-modified low-density lipoprotein with coronary plaque morphology in patients with coronary spastic angina: Implication of acute coronary eventsTANI, Shigemasa; NAGAO, Ken; SATO, Yuichi et al.International journal of cardiology. 2009, Vol 135, Num 2, pp 202-206, issn 0167-5273, 5 p.Article

Relation of Change in Apolipoprotein B/Apolipoprotein A-I Ratio to Coronary Plaque Regression After Pravastatin Treatment in Patients With Coronary Artery DiseaseTANI, Shigemasa; NAGAO, Ken; HIRAYAMA, Atsushi et al.The American journal of cardiology. 2010, Vol 105, Num 2, pp 144-148, issn 0002-9149, 5 p.Article

Association of Leukocyte Subtype Counts With Coronary Atherosclerotic Regression Following Pravastatin TreatmentTANI, Shigemasa; NAGAO, Ken; HIRAYAMA, Atsushi et al.The American journal of cardiology. 2009, Vol 104, Num 4, pp 464-469, issn 0002-9149, 6 p.Article

Association of circulating leukocyte count with coronary atherosclerosis regression after pravastatin treatmentTANI, Shigemasa; NAGAO, Ken; ANAZAWA, Takeo et al.Atherosclerosis. 2008, Vol 198, Num 2, pp 360-365, issn 0021-9150, 6 p.Article